Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL822393 | 0.96 | GPR84 (0.55) | GPR84FFAR1NAAAACHEZDHHC7 | |
| SCHEMBL13658517 | 0.96 | GPR84 (0.55) | GPR84FFAR1NAAAACHEZDHHC7 | |
| SCHEMBL957003 | 0.96 | GPR84 (0.55) | GPR84FFAR1NAAAACHEZDHHC7 | |
| SCHEMBL3790426 | 0.96 | GPR84 (0.55) | GPR84FFAR1NAAAACHEZDHHC7 | |
| SCHEMBL821842 | 0.95 | GPR84 (0.52) | GPR84FFAR1NAAAACHEZDHHC7 | |
| Propene SCHEMBL141131 | 0.92 | GPR84 (0.47) | GPR84FFAR1NAAAACHEZDHHC7 | |
| Ethylene SCHEMBL1278218 | 0.91 | GPR84 (0.57) | GPR84FFAR1NAAAZDHHC7MAPT | |
| SCHEMBL822143 | 0.89 | ACHE (0.47) | GPR84FFAR1NAAAACHEMEN1 | |
| SCHEMBL3804116 | 0.87 | MGLL (0.55) | GPR84FFAR1FFAR4 | |
| SCHEMBL3804114 | 0.87 | MGLL (0.55) | GPR84FFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 358 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110114121-B | Stabilization of cosmetic compositions comprising fish oil and hydroxylated fatty acid and/or derivative thereof | 联合利华知识产权控股有限公司 | 2022-05-24 | — | — | CN | claimed |
| US-5006170-A | Thermal ink jet printing, binders, propellants | XEROX CORPORATION (US) | 1991-04-09 | — | — | US | claimed |
| US-4173492-A | Method of preparing coated pigment particles and the product produced thereby | POLLARD EDWARD T | 1979-11-06 | — | — | US | claimed |
| EP-4736154-A1 | ELECTROPHORETIC DEVICE WITH AMBIENT LIGHT SENSOR AND ADAPTIVE WHITENESS RESTORING AND COLOR BALANCING FRONTLIGHT | E Ink Corporation (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12606713-B2 | Electrophoretic media including charge control agents comprising quartenary amines and unsaturated polymeric tails | E INK CORPORATION (US) | 2026-04-21 | — | — | US | disclosed |
| EP-4721044-A1 | COLOR ELECTROPHORETIC MEDIUM HAVING FOUR PIGMENT PARTICLE SYSTEM ADDRESSABLE BY WAVEFORMS HAVING FOUR VOLTAGE LEVELS | E Ink Corporation (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20250363962-A1 | ELECTROPHORETIC DEVICE WITH AMBIENT LIGHT SENSOR AND ADAPTIVE WHITENESS RESTORING AND COLOR BALANCING FRONTLIGHT | E INK CORP (US) | 2025-11-27 | — | — | US | disclosed |
| US-12454598-B2 | Charge control agents and particle dispersions including the same | E INK CORPORATION (US) | 2025-10-28 | — | — | US | disclosed |
| US-12412538-B2 | Electrophoretic device with ambient light sensor and adaptive whiteness restoring and color balancing frontlight | E INK CORPORATION (US) | 2025-09-09 | — | — | US | disclosed |
| WO-2025136446-A1 | FIVE-PARTICLE ELECTROPHORETIC MEDIUM WITH IMPROVED BLACK OPTICAL STATE | E INK CORPORATION (US) | 2025-06-26 | — | — | WO | disclosed |
| EP-3571548-B1 | COLOR ORGANIC PIGMENTS AND ELECTROPHORETIC DISPLAY MEDIA CONTAINING THE SAME | E INK CORP (US) | 2025-06-11 | — | — | EP | disclosed |
| US-4681831-A | NONPOLAR LIQUID, ANIONIC POLYMERS, IONIC OR ZWITTERIONIC CHARGE DIRECTOR | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-07-21 | — | — | US | disclosed |
| US-4173492-A | Method of preparing coated pigment particles and the product produced thereby | POLLARD EDWARD T | 1979-11-06 | — | — | US | disclosed |
| US-4143890-A | MICROENCAPSULATION, DUPLICATION, CHROMOGENS | THE MEAD CORPORATION (US) | 1979-03-13 | — | — | US | disclosed |
| US-4139392-A | CARBONLESS COPYING | THE MEAD CORPORATION (US) | 1979-02-13 | — | — | US | disclosed |
| US-4139218-A | NONAQUEOUS, SOLVENT-FREE HOT MELT ADHESIVE SUSPENSION OF MICROENCAPSULATED CHROMOGENS, POLARITY | THE MEAD CORPORATION (US) | 1979-02-13 | — | — | US | disclosed |
| US-4137343-A | Process for producing pressure-sensitive carbonless transfer sheets | THE MEAD CORPORATION (US) | 1979-01-30 | — | — | US | disclosed |
| US-4111823-A | DRY DEVELOPING POWDER INCLUDING TONER POWDERS OF DIFFERENT PARTICLE SIZE | RICOH CO., LTD. (JP) | 1978-09-05 | — | — | US | disclosed |
| US-4112138-A | Manifold carbonless form and process for the production thereof | THE MEAD CORPORATION (US) | 1978-09-05 | — | — | US | disclosed |
| US-4097619-A | Manifold carbonless form and process for the continuous production thereof | THE MEAD CORPORATION (US) | 1978-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606713-B2 | Electrophoretic media including charge control agents comprising quartenary amines and unsaturated polymeric tails | AAAS, PARG, PARN | GPR84 2857/4885FFAR1 2790/4885NAAA 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.